Correlation Between Medipharm Labs and HLS Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medipharm Labs Corp and HLS Therapeutics, you can compare the effects of market volatilities on Medipharm Labs and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and HLS Therapeutics.

Diversification Opportunities for Medipharm Labs and HLS Therapeutics

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Medipharm and HLS is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and HLS Therapeutics go up and down completely randomly.

Pair Corralation between Medipharm Labs and HLS Therapeutics

Assuming the 90 days horizon Medipharm Labs Corp is expected to generate 1.08 times more return on investment than HLS Therapeutics. However, Medipharm Labs is 1.08 times more volatile than HLS Therapeutics. It trades about 0.01 of its potential returns per unit of risk. HLS Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  6.20  in Medipharm Labs Corp on November 2, 2024 and sell it today you would lose (1.76) from holding Medipharm Labs Corp or give up 28.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.4%
ValuesDaily Returns

Medipharm Labs Corp  vs.  HLS Therapeutics

 Performance 
       Timeline  
Medipharm Labs Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's forward indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
HLS Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Medipharm Labs and HLS Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medipharm Labs and HLS Therapeutics

The main advantage of trading using opposite Medipharm Labs and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.
The idea behind Medipharm Labs Corp and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities